| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Adaptimmune Therapeutics PLC | Chief Financial Officer | Ordinary Shares with a nominal value of GBP0.001 per share | 0 | $0 | $0.0800 | 02 Sep 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ADAP | Adaptimmune Therapeutics PLC | 02 Sep 2025 | 1 | -$950 | 4 | Chief Financial Officer | 03 Sep 2025, 17:00 |
| ADAP | Adaptimmune Therapeutics PLC | 15 Jan 2024 | 2 | $0 | 4 | Chief Financial Officer | 17 Jan 2024, 17:01 |
| ADAP | Adaptimmune Therapeutics PLC | 17 Jan 2023 | 3 | $0 | 4 | Chief Financial Officer | 17 Jan 2023, 20:04 |
| ADAP | Adaptimmune Therapeutics PLC | 20 May 2022 | 1 | +$11,326 | 4 | Chief Financial Officer | 23 May 2022, 21:00 |
| ADAP | Adaptimmune Therapeutics PLC | 12 Jan 2022 | 2 | $0 | 4 | Chief Financial Officer | 13 Jan 2022, 20:03 |